RICHARD G VINCENT
CIK 1269341 · Chief Financial Officer · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
29
Lifetime Open-Market Net
$37.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 3
29 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-11 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | +48,988 | $0 | EDGAR |
| 2014-10-09 | SRNE | Grant (A) | — | $0 | EDGAR |
| 2013-10-31 | SRNE | Grant (A) | — | $0 | EDGAR |
| 2012-10-19 | — | Disp (D) | — | $0 | |
| 2012-10-19 | — | Disp (D) | — | $0 | |
| 2012-09-25 | — | Grant (A) | — | $0 | |
| 2012-02-07 | — | Grant (A) | — | $0 | |
| 2011-03-09 | — | Grant (A) | — | $0 | |
| 2010-02-09 | — | Grant (A) | — | $0 |
Showing 21–29 of 29
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.